Matches in Nanopublications for { ?s ?p "[Furthermore, expression of a dominant-negative form of TCF in colon-cancer cells strongly inhibits expression of cyclin D1 without affecting expression of cyclin D2, cyclin E, or cyclin-dependent kinases 2, 4 or 6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Furthermore, expression of a dominant-negative form of TCF in colon-cancer cells strongly inhibits expression of cyclin D1 without affecting expression of cyclin D2, cyclin E, or cyclin-dependent kinases 2, 4 or 6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Furthermore, expression of a dominant-negative form of TCF in colon-cancer cells strongly inhibits expression of cyclin D1 without affecting expression of cyclin D2, cyclin E, or cyclin-dependent kinases 2, 4 or 6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Furthermore, expression of a dominant-negative form of TCF in colon-cancer cells strongly inhibits expression of cyclin D1 without affecting expression of cyclin D2, cyclin E, or cyclin-dependent kinases 2, 4 or 6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP249989.RARkxLH4Mso2fzuXCpmNaPD0teqQQ3mz4JX9PYfPCfn5w130_assertion description "[Furthermore, expression of a dominant-negative form of TCF in colon-cancer cells strongly inhibits expression of cyclin D1 without affecting expression of cyclin D2, cyclin E, or cyclin-dependent kinases 2, 4 or 6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP249989.RARkxLH4Mso2fzuXCpmNaPD0teqQQ3mz4JX9PYfPCfn5w130_provenance.
- NP249992.RATfQRQuLA5qgquMKuquwlVjfsUo1f-S59Ht3p1Tqe-UY130_assertion description "[Furthermore, expression of a dominant-negative form of TCF in colon-cancer cells strongly inhibits expression of cyclin D1 without affecting expression of cyclin D2, cyclin E, or cyclin-dependent kinases 2, 4 or 6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP249992.RATfQRQuLA5qgquMKuquwlVjfsUo1f-S59Ht3p1Tqe-UY130_provenance.
- NP461216.RA2hiIsrpNcLSJ_O1Gukc-zl6Tb3-Z9oa4R8cuf79kJEE130_assertion description "[Furthermore, expression of a dominant-negative form of TCF in colon-cancer cells strongly inhibits expression of cyclin D1 without affecting expression of cyclin D2, cyclin E, or cyclin-dependent kinases 2, 4 or 6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461216.RA2hiIsrpNcLSJ_O1Gukc-zl6Tb3-Z9oa4R8cuf79kJEE130_provenance.
- NP461506.RAP95nCU2SMJuQwWRZFOY0_Y40NIRo_OYqfel9s2-McuA130_assertion description "[Furthermore, expression of a dominant-negative form of TCF in colon-cancer cells strongly inhibits expression of cyclin D1 without affecting expression of cyclin D2, cyclin E, or cyclin-dependent kinases 2, 4 or 6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461506.RAP95nCU2SMJuQwWRZFOY0_Y40NIRo_OYqfel9s2-McuA130_provenance.
- NP249993.RANh1gjUJxgKLWW3QoLZA2tbQD8B2iyioYQzAmfsCDrMo130_assertion description "[Furthermore, expression of a dominant-negative form of TCF in colon-cancer cells strongly inhibits expression of cyclin D1 without affecting expression of cyclin D2, cyclin E, or cyclin-dependent kinases 2, 4 or 6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP249993.RANh1gjUJxgKLWW3QoLZA2tbQD8B2iyioYQzAmfsCDrMo130_provenance.